Stay updated with breaking news from Development Solutions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
IQVIA beats Q4 2023 sales expectations, reporting $3.87 billion (3.5% Y/Y). Adjusted EPS of $2.84 exceeds guidance. IQV's 2023 performance and optimistic 2024 outlook.
Aviva PLC increased its stake in IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 5.3% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 515,611 shares of the medical research company’s stock after purchasing an additional 26,084 shares during the quarter. Aviva PLC’s holdings […]
IQVIA (NYSE:IQV – Get Free Report) updated its FY 2024 earnings guidance on Wednesday. The company provided earnings per share guidance of 10.950-11.250 for the period, compared to the consensus earnings per share estimate of 11.060. The company issued revenue guidance of $15.4 billion-$15.7 billion, compared to the consensus revenue estimate of $15.6 billion. IQVIA […]
UBS Group AG lowered its stake in shares of IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 8.1% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 369,491 shares of the medical research company’s stock after selling 32,479 shares during the quarter. […]
UBS Group AG lowered its stake in shares of IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 8.1% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 369,491 shares of the medical research company’s stock after selling 32,479 shares during the period. UBS Group AG’s holdings in IQVIA were worth $72,697,000 at the end […]